Continuous Glucose Monitoring Systems Market by Components, Demographics, and Adult Population, and End User - Global Opportunity Analysis and Industry Forecast, 2016-2024

  • ID: 4580589
  • Report
  • Region: Global
  • 267 pages
  • Allied Analytics LLP
1 of 4
Continuous glucose monitoring (CGM) is one of the latest technological advancements in the field of diabetes management. CGM system is a type of glucose monitoring device that functions by inserting a biosensor through transcutaneous or subcutaneous route. The embedded sensor measures the glucose levels in interstitial fluid or blood, and transmits the information using a transmitter to a receiver/monitor for displaying the results. These systems play an integral role in diabetes management, owing to their associated several advantages over other glucose monitoring devices. Unlike conventional glucose monitors, these systems enable periodic monitoring of glucose levels, which is crucial for avoiding diabetic complications. In addition, CGMS technology has laid a roadmap to the most awaited, high-tech, closed-loop artificial/bionic pancreas. Therefore, development of novel and technologically advanced CGMS is the prime focus of glucose monitoring device manufacturing companies. It offers a wide range of applications for all age-cohorts, healthcare settings (diagnostic centers/clinics, hospital ICUs, and home healthcare), and geographies. Thus, CGMS market poses lucrative opportunity for both CGMS manufacturers and insulin pump manufacturers.

The global CGMS market generated $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% during the forecast period. The pipeline of high-tech CGMS devices, such as smartphone-connected CGMS, wearable & smartphone-connected CGMS, non-invasive CGMS and ‘smart’ diabetes management solution (also called artificial/bionic pancreas), is expected to result in higher adoption of CGMS among endocrinologists and patients.

The market is categorized based on component, demographics, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years. On the basis of demographics, CGMS devices are categorized into child population (=14 years) and adult population (>14 years).

The report includes comprehensive geographical analysis and segmentation of geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA. The major strategies adopted by market players are collaborations, product launches, and product approvals. The adoption of collaboration strategy by companies enables greater focus on innovation, distribution, and commercialization of devices.

KEY BENEFITS

This report provides an extensive analysis of the current and emerging trends, and dynamics in the global CGMS market to identify the prevailing opportunities.
It presents a competitive landscape of the global market to predict the market scenario across geographies.
A comprehensive analysis of factors that drive and restrict the market growth is provided.
The region- and country-wise analyses are provided to understand the market trends and dynamics.

KEY MARKET SEGMENTS

By Component

Sensors
Transmitters & Receivers
Integrated Insulin Pumps

By Demographics

Child Population (=14 years)
Adult Population (>14 years)

By End User

Diagnostics & Clinics
ICUs
Home Healthcare

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Norway
Sweden
Denmark
Finland
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Venezuela
Argentina
Rest of LAMEA

The key players profiled in this report are as follows:

Abbott Laboratories
Dexcom, Inc.
A. Menarini Diagnostics
Echo Therapeutics, Inc.
GlySens Incorporated
Johnson & Johnson
Insulet Corporation
Medtronic plc
Senseonics Holdings, Inc.
F. Hoffmann-La Roche Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition
3.2. Need for glucose monitoring systems
3.2.1. Diabetes-a pandemic
3.2.1.1. Type 1 diabetes
3.2.1.2. Type-2 diabetes
3.2.1.3. Prediabetes and gestational diabetes mellitus (GDM)
3.2.1.4. Gestational diabetes mellitus (GDM)
3.2.1.5. Secondary diabetes
3.2.1.6. Global healthcare expenditure on diabetes
3.3. Key Findings
3.3.1. Top investment pockets
3.3.2. Top winning strategies
3.3.3. Value Chain Analysis
3.4. Patent analysis
3.4.1. Patent analysis, by market participant
3.4.2. U.S. patent analysis, by market participant
3.4.3. Patent analysis, by year
3.5. Market Share Analysis, 2017
3.6. Government Regulations
3.6.1. FDA regulations (21CFR820)
3.6.1.1. Objective and Scope of FDA 21CFR820
3.6.2. ISO regulations (ISO 13485:2003)
3.6.2.1. Objective and Scope of ISO 13485:2003
3.7. Reimbursement Scenario
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Benefits of CGMS over POC glucometers
3.8.1.2. Rise in incidence of diabetes cases
3.8.1.3. Technological advancements
3.8.2. Restraints
3.8.2.1. Adverse effects and accuracy
3.8.2.2. Reimbursement and stringent regulatory issues
3.8.3. Opportunities
3.8.3.1. High adoption rate of CGMS in home healthcare and ICUs
3.8.3.2. Increase in product awareness
3.8.3.3. High undiagnosed patient population
3.8.4. Impact analyses

CHAPTER 4: CONTINOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Sensors
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Transmitters & Receivers
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Integrated Insulin pumps
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast

CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHICS
5.1. Overview
5.1.1. Market size and forecast
5.2. Adult Population (>14 years)
5.2.1. Market size and forecast
5.3. Children Population (14 years)
5.3.1. Market size and forecast

CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Diagnostic centers/clinics
6.2.1. Market size and forecast
6.3. ICUs
6.3.1. Market size and forecast
6.4. Home Healthcare
6.4.1. Market size and forecast

CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America continuous glucose monitoring systems market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. continuous glucose monitoring systems market size and forecast, by component
7.2.2.1.2. U.S. continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.1.3. U.S. continuous glucose monitoring systems market size and forecast, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada continuous glucose monitoring systems market size and forecast, by component
7.2.2.2.2. Canada continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.2.3. Canada continuous glucose monitoring systems market size and forecast, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico continuous glucose monitoring systems market size and forecast, by component
7.2.2.3.2. Mexico continuous glucose monitoring systems market size and forecast, by demographics
7.2.2.3.3. Mexico continuous glucose monitoring systems market size and forecast, by end user
7.2.3. North America continuous glucose monitoring systems market size and forecast, by component
7.2.4. North America continuous glucose monitoring systems market size and forecast, by demographics
7.2.5. North America continuous glucose monitoring systems market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe continuous glucose monitoring systems market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany continuous glucose monitoring systems market size and forecast, by component
7.3.2.1.2. Germany continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.1.3. Germany continuous glucose monitoring systems market size and forecast, by end user
7.3.2.2. France
7.3.2.2.1. France continuous glucose monitoring systems market size and forecast, by component
7.3.2.2.2. France continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.2.3. France continuous glucose monitoring systems market size and forecast, by end user
7.3.2.3. UK
7.3.2.3.1. UK continuous glucose monitoring systems market size and forecast, by component
7.3.2.3.2. UK continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.3.3. UK continuous glucose monitoring systems market size and forecast, by end user
7.3.2.4. Spain
7.3.2.4.1. Spain continuous glucose monitoring systems market size and forecast, by component
7.3.2.4.2. Spain continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.4.3. Spain continuous glucose monitoring systems market size and forecast, by end user
7.3.2.5. Italy
7.3.2.5.1. Italy continuous glucose monitoring systems market size and forecast, by component
7.3.2.5.2. Italy continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.5.3. Italy continuous glucose monitoring systems market size and forecast, by end user
7.3.2.6. Netherlands
7.3.2.6.1. Netherlands continuous glucose monitoring systems market size and forecast, by component
7.3.2.6.2. Netherlands continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.6.3. Netherlands continuous glucose monitoring systems market size and forecast, by end user
7.3.2.7. Norway
7.3.2.7.1. Norway continuous glucose monitoring systems market size and forecast, by component
7.3.2.7.2. Norway continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.7.3. Norway continuous glucose monitoring systems market size and forecast, by end user
7.3.2.8. Sweden
7.3.2.8.1. Sweden continuous glucose monitoring systems market size and forecast, by component
7.3.2.8.2. Sweden continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.8.3. Sweden continuous glucose monitoring systems market size and forecast, by end user
7.3.2.9. Denmark
7.3.2.9.1. Denmark continuous glucose monitoring systems market size and forecast, by component
7.3.2.9.2. Denmark continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.9.3. Denmark continuous glucose monitoring systems market size and forecast, by end user
7.3.2.10. Finland
7.3.2.10.1. Finland continuous glucose monitoring systems market size and forecast, by component
7.3.2.10.2. Finland continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.10.3. Finland continuous glucose monitoring systems market size and forecast, by end user
7.3.2.11. Rest of Europe
7.3.2.11.1. Rest of Europe continuous glucose monitoring systems market size and forecast, by component
7.3.2.11.2. Rest of Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.2.11.3. Rest of Europe continuous glucose monitoring systems market size and forecast, by end user
7.3.3. Europe continuous glucose monitoring systems market size and forecast, by component
7.3.4. Europe continuous glucose monitoring systems market size and forecast, by demographics
7.3.5. Europe continuous glucose monitoring systems market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific continuous glucose monitoring systems market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan continuous glucose monitoring systems market size and forecast, by component
7.4.2.1.2. Japan continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.1.3. Japan continuous glucose monitoring systems market size and forecast, by end user
7.4.2.2. China
7.4.2.2.1. China continuous glucose monitoring systems market size and forecast, by component
7.4.2.2.2. China continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.2.3. China continuous glucose monitoring systems market size and forecast, by end user
7.4.2.3. India
7.4.2.3.1. India continuous glucose monitoring systems market size and forecast, by component
7.4.2.3.2. India continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.3.3. India continuous glucose monitoring systems market size and forecast, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia continuous glucose monitoring systems market size and forecast, by component
7.4.2.4.2. Australia continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.4.3. Australia continuous glucose monitoring systems market size and forecast, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea continuous glucose monitoring systems market size and forecast, by component
7.4.2.5.2. South Korea continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.5.3. South Korea continuous glucose monitoring systems market size and forecast, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.2.6.2. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.2.6.3. Rest of Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user
7.4.3. Asia-Pacific continuous glucose monitoring systems market size and forecast, by component
7.4.4. Asia-Pacific continuous glucose monitoring systems market size and forecast, by demographics
7.4.5. Asia-Pacific continuous glucose monitoring systems market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA continuous glucose monitoring systems market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil continuous glucose monitoring systems market size and forecast, by component
7.5.2.1.2. Brazil continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.1.3. Brazil continuous glucose monitoring systems market size and forecast, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia continuous glucose monitoring systems market size and forecast, by component
7.5.2.2.2. Saudi Arabia continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.2.3. Saudi Arabia continuous glucose monitoring systems market size and forecast, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa continuous glucose monitoring systems market size and forecast, by component
7.5.2.3.2. South Africa continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.3.3. South Africa continuous glucose monitoring systems market size and forecast, by end user
7.5.2.4. Venezuela
7.5.2.4.1. Venezuela continuous glucose monitoring systems market size and forecast, by component
7.5.2.4.2. Venezuela continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.4.3. Venezuela continuous glucose monitoring systems market size and forecast, by end user
7.5.2.5. Argentina
7.5.2.5.1. Argentina continuous glucose monitoring systems market size and forecast, by component
7.5.2.5.2. Argentina continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.5.3. Argentina continuous glucose monitoring systems market size and forecast, by end user
7.5.2.6. Rest of LAMEA
7.5.2.6.1. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.2.6.2. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.2.6.3. Rest of LAMEA continuous glucose monitoring systems market size and forecast, by end user
7.5.3. LAMEA continuous glucose monitoring systems market size and forecast, by component
7.5.4. LAMEA continuous glucose monitoring systems market size and forecast, by demographics
7.5.5. LAMEA continuous glucose monitoring systems market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES
8.1. Abbott Laboratories
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. A. Menarini Diagnostics S.r.l.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. DexCom, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Business performance
8.3.5. Key strategic moves and developments
8.4. Echo Therapeutics, Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. F. Hoffmann-La Roche Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. GlySens Incorporated
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.6.4. Key strategic moves and developments
8.7. Insulet Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Business performance
8.7.5. Key strategic moves and developments
8.8. Johnson & Johnson
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments
8.9. Medtronic Plc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Senseonics Holdings, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, "Continuous Glucose Monitoring Systems (CGMS) Market by Components, Demographics, and End Userlobal Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $894 million in 2016, and is projected to reach $4,921 million by 2024, registering a CAGR of 22.9% from 2018 to 2024.

The continuous glucose monitoring systems (CGMS) market has emerged as a promising diabetes management tool for monitoring all types of diabetic patients. Replacement/repeat sales of components such as sensors drive the growth of the CGMS market. Continuous glucose monitoring systems are mainly used by patients suffering from hypo and hyperglycemic conditions. Rise in incidences of diabetes worldwide, benefits of CGMS devices over POC glucometers, increase in awareness in developing and underdeveloped economies, and technological advancements with focus on developing CGMS devices majorly drive the CGM market. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.

By component, sensors generated the maximum revenue, accounting for more than two-thirds share of the global continuous glucose monitoring systems market in 2016. By demographics, adult population was the highest revenue generating segment in 2016 while child population was the segment with the highest CAGR during the forecast period

Key Findings of the Continuous Glucose Monitoring Systems (CGMS) Market

The sensors segment contributed for nearly two-third share of the global continuous glucose monitoring systems market in 2016.
The integrated insulin pumps segment is projected to grow at a significant CAGR of 17.3% from 2018 to 2023.
The ICUs segment is projected to grow at a significant CAGR of 22.3% during the forecast period.
Germany and France are the major shareholders, which collectively accounted for more than one-fourth share of the European continuous glucose monitoring systems market in 2016.
Japan is the major shareholder, accounting for more than one-fourth share of the Asia-Pacific continuous glucose monitoring systems market in 2016.

Geographical analysis shows, North America and Europe are the most lucrative market segments in the global CGMs market. High purchasing power that renders increased affordability for CGMS devices are the key factors responsible for the growth of this market in Europe and North America. Asia-Pacific market is expected to grow at a highest CAGR of 29.7% over the analysis period and thus constitutes potential market opportunity for the new market players. Moreover, factors such as rise in the number of patients with diabetes, growth in the purchasing power of the patients and awareness can positively impact the growth of the market in this region.

The major companies profiled in the report are Abbott Laboratories, Dexcom, Inc., A. Menarini Diagnostics, Echo Therapeutics, Inc., Insulet Corporation, GlySens Incorporated, Johnson & Johnson, Medtronic plc, Senseonics Holdings, Inc., and F. Hoffmann-La Roche Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll